Medicare GLP-1 Access: A new “Bridge” program starts letting some seniors get lower-cost GLP-1 weight-loss drugs, but only temporarily—raising questions about what happens after coverage ends. Medicare Fraud Sentencing: A Georgia nurse practitioner was sentenced to 10 years for a $136M Medicare scheme selling medically unnecessary braces and drugs, with kickbacks to clinicians. Sleep & Weight Link: A Columbia pooled analysis finds that cutting sleep by about 90 minutes nightly for six weeks can lead to weight gain in adults. Cancer Drug Development: The EMA has begun a phased review of daraxonrasib for metastatic pancreatic cancer, aiming to speed assessment for a high-unmet-need population. Obesity Tech & Trials: Novo Nordisk is partnering with Vivani Medical on a miniature, ultra long-acting semaglutide implant for chronic weight management, with early human testing planned. Healthcare Access & Policy: Planned Parenthood affiliates can resume Medicaid billing for non-abortion services after a federal defunding ban lapsed, though not all cut services are expected to return. Global Health: Ebola response in DR Congo faces disruption risk as health workers threaten strikes over pay and supplies. Local Care Expansion: MCR Health launched its inaugural podiatry residency program in Southwest Florida, adding training capacity for future clinicians.